Browsing Wolfson Institute of Preventive Medicine by Author "Loughman, T"
Now showing items 1-2 of 2
-
Evaluation of the OncoMasTR prognostic signature in postmenopausal women with primary ER-positive breast cancer.
Sestak, I; Buus, R; Cuzick, JM; Barron, S; Loughman, T; Fender, B; Ruiz, CL; Dynoodt, P; Wang, C-JA; O'Leary, D (American Society of Clinical Oncology, 2018-05-20)Background: The assessment of distant recurrence (DR) risk in patients with early estrogen receptor (ER) positive breast cancer receiving adjuvant endocrine therapy is essential in making decisions on additional treatment. ... -
Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC study.
Buus, R; Sestak, I; Barron, S; Loughman, T; Fender, B; Ruiz, CL; Dynoodt, P; Wang, C-JA; O'Leary, D; Gallagher, WM (2020-02-01)PURPOSE: To test the validity of OncoMasTR Molecular Score (OMm), OMclin1, and OncoMasTR Risk Score (OMclin2) prognostic scores for prediction of distant recurrence (DR) in estrogen receptor (ER)-positive/HER2-negative ...